Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | References |
Homo sapiens | RAR-related orphan receptor C | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | O-methyltransferase | 0.0062 | 0.0359 | 0.0539 |
Brugia malayi | O-methyltransferase family protein | 0.0062 | 0.0359 | 0.0281 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0127 | 0.1532 | 0.1725 |
Mycobacterium ulcerans | methyltransferase | 0.0062 | 0.0359 | 0.0359 |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Brugia malayi | O-methyltransferase family protein | 0.0062 | 0.0359 | 0.0281 |
Trichomonas vaginalis | serine threonine-protein kinase, putative | 0.0051 | 0.0153 | 0.0374 |
Loa Loa (eye worm) | glutaminase | 0.027 | 0.4103 | 1 |
Brugia malayi | O-methyltransferase family protein | 0.0062 | 0.0359 | 0.0281 |
Onchocerca volvulus | 0.0062 | 0.0359 | 0.5 | |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0114 | 0.1302 | 0.1466 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0051 | 0.0153 | 0.0374 |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Leishmania major | trypanothione reductase | 0.005 | 0.0146 | 0.5 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0042 | 0 | 0.5 |
Brugia malayi | O-methyltransferase | 0.0062 | 0.0359 | 0.0281 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.005 | 0.0146 | 0.0587 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0114 | 0.1302 | 0.1466 |
Mycobacterium tuberculosis | Probable catechol-O-methyltransferase | 0.0536 | 0.8883 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0114 | 0.1302 | 0.1466 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.2479 | 0.6041 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0114 | 0.1302 | 0.85 |
Echinococcus multilocularis | serine:threonine protein kinase:endoribonuclease | 0.0099 | 0.103 | 0.4155 |
Plasmodium falciparum | glutathione reductase | 0.005 | 0.0146 | 1 |
Loa Loa (eye worm) | IRE protein kinase | 0.0099 | 0.103 | 0.2235 |
Trichomonas vaginalis | glutaminase, putative | 0.027 | 0.4103 | 1 |
Echinococcus granulosus | serine:threonine protein kinase:endoribonuclease | 0.0099 | 0.103 | 0.4155 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.005 | 0.0146 | 0.5 |
Brugia malayi | glutaminase DH11.1 | 0.027 | 0.4103 | 0.5209 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0127 | 0.1532 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0127 | 0.1532 | 0.1725 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0359 | 0.0539 |
Brugia malayi | Ribonuclease 2-5A family protein | 0.0099 | 0.103 | 0.1164 |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Mycobacterium ulcerans | glutaminase | 0.027 | 0.4103 | 0.4103 |
Schistosoma mansoni | o-methyltransferase | 0.0062 | 0.0359 | 0.0875 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0114 | 0.1302 | 0.1466 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0127 | 0.1532 | 0.1725 |
Entamoeba histolytica | protein kinase, putative | 0.0099 | 0.103 | 0.5 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.005 | 0.0146 | 0.0587 |
Echinococcus multilocularis | geminin | 0.018 | 0.2479 | 1 |
Mycobacterium leprae | PROBABLE METHYLTRANSFERASE | 0.0062 | 0.0359 | 0.2343 |
Plasmodium vivax | thioredoxin reductase, putative | 0.005 | 0.0146 | 1 |
Mycobacterium tuberculosis | Probable methyltransferase | 0.0062 | 0.0359 | 0.0404 |
Plasmodium vivax | glutathione reductase, putative | 0.005 | 0.0146 | 1 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0472 | 0.7743 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.005 | 0.0146 | 1 |
Schistosoma mansoni | hypothetical protein | 0.018 | 0.2479 | 0.6041 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.005 | 0.0146 | 0.0164 |
Plasmodium falciparum | thioredoxin reductase | 0.005 | 0.0146 | 1 |
Mycobacterium tuberculosis | Probable L-lysine-epsilon aminotransferase Lat (L-lysine aminotransferase) (lysine 6-aminotransferase) | 0.0472 | 0.7743 | 0.8716 |
Mycobacterium tuberculosis | Probable reductase | 0.0114 | 0.1302 | 0.1466 |
Trypanosoma brucei | trypanothione reductase | 0.005 | 0.0146 | 0.5 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0114 | 0.1302 | 0.1466 |
Schistosoma mansoni | glutaminase | 0.027 | 0.4103 | 1 |
Onchocerca volvulus | 0.0062 | 0.0359 | 0.5 | |
Mycobacterium ulcerans | L-lysine aminotransferase | 0.0472 | 0.7743 | 0.7743 |
Wolbachia endosymbiont of Brugia malayi | O-methyltransferase | 0.0062 | 0.0359 | 1 |
Echinococcus granulosus | geminin | 0.018 | 0.2479 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0051 | 0.0159 | 0.0387 |
Entamoeba histolytica | protein kinase, putative | 0.0099 | 0.103 | 0.5 |
Loa Loa (eye worm) | glutaminase 2 | 0.027 | 0.4103 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
%max (binding) | = 102 % | Inhibition of N-(2-chloro-6-fluorobenzyl)-N-((2'-methoxy-[1,1'-biphenyl]-4-yl)methyl)benzenesulfonamide-induced APC-labeled RORgammat receptor ligand binding domain (unknown origin) after 1 hr by FRET assay | ChEMBL. | 24388993 |
IC50 (binding) | = 6.1 | Inhibition of RORgammat receptor ligand binding domain in mouse spleen CD4+ T cells assessed as inhibition of IL-17 production after 3 days by ELISA | ChEMBL. | 24388993 |
IC50 (binding) | = 7.4 | Inhibition of APC-labeled RORgammat receptor ligand binding domain (unknown origin) after 1 hr by FRET assay | ChEMBL. | 24388993 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.